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POTENTIAL TREATMENT OF INFLAMMATORY AND PROLIFERATIVE DIS-
EASES BY ULTRA-LOW DOSES OF IONIZING RADIATIONS
Charles L. Sanders  Department of Nuclear and Quantum Engineering, Korea
Advanced Institute of Science and Technology, Daejeon, Korea and 2030 New
Hampshire Street, Loveland, CO 80538
 Ultra-low doses and dose- rates of ionizing radiation are effective in preventing disease
which suggests that they also may be effective in treating disease. Limited experimental
and anecdotal evidence indicates that low radiation doses from radon in mines and spas,
thorium-bearing monazite sands and enhanced radioactive uranium ore obtained from a
natural geological reactor may be useful in treating many inflammatory conditions and
proliferative disorders, including cancer. Optimal therapeutic applications were identified
via a literature survey as dose-rates ranging from 7 to 11µGy/hr or 28 to 44 times world
average background rates. Rocks from an abandoned uranium mine in Utah were con-
sidered for therapeutic application and were examined by γ-ray and laser-induced break-
down fluorescence spectroscopy. The rocks showed the presence of transuranics and fis-
sion products with a γ-ray energy profile similar to aged spent uranium nuclear fuel (93%
dose due to β particles and 7% due to γ rays). Mud packs of pulverized uranium ore rock
dust in sealed plastic bags delivering bag surface β,γ dose-rates of 10-450 µGy/h were used
with apparent success to treat several inflammatory and proliferative conditions in
humans.
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INTRODUCTION
Radiation standards in 1934 were 1 mSv/day for the NCRP [National
Council of Radiation Protection & Measurements] and 2 mSv/day for the
ICRP [International Commission on Radiological Protection]. Neither
dose limit was associated with a measurable increased risk of cancer or
any other disease (Taylor 1980). Low doses of γ-and x-rays and low dose-
rates from β- and γ-rays exhibit significant hormetic effects based on
many observations in epidemiological and experimental studies (Luckey
2008a; Sanders 2010). Protective adaptive response mechanisms are acti-
vated by low linear-energy-transfer (LET) radiation doses < 100 mSv (or
combined low- and high-LET doses in the indicated range) that can result
in reduction in the level of inflammatory and proliferative diseases
(Dauer et al. 2010). Low doses of ionizing radiation may be useful in pre-
venting cancers in high-risk populations, such as in heavy cigarette smok-
ers, as well as in curing early stage cancers (Scott and Di Palma 2006;
Sanders 2008).
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Natural radiation sources are available that may have therapeutic
application. A natural nuclear reactor was revealed in Oklo in Gabon,
Africa in an area containing a 70% uranium oxide ore seam up to
meter(s) thick. Both fission products and transuranic radionuclides were
found at this site. Overall, the isotopic composition of the Gabon urani-
um ore resembled that of aged spent nuclear fuel (Cowan 1976; Meshik
2004). A natural nuclear reactor(s) appears also to have been operational
in a high uranium sandstone formation of the Colorado Plateau.
A variety of developing, but rudimentary, low-dose radiation therapy
strategies have been evaluated with respect to treating chronic inflamma-
tory and proliferative diseases using natural radiation sources (Yamaoka
et al. 2004;Falkenbach et al. 2005; Takatori et al. 2010; Lewis 2011). These
include radon therapy in abandoned mines and spas, therapy using tho-
rium-bearing monazite sand, ultra-low doses of x-ray and γ-ray exposures
and β/γ exposures from uranium-bearing rocks resembling aged spent
nuclear fuel.
METHODS AND RESULTS
Radioactive sandstone rocks for use in low-dose radiation therapy
were obtained from an abandoned uranium mine near Monticello in San
Juan County, UT. Ore from this mine contained the highest concentra-
tion of uranium (up to 87% U3O8). The ore was contained within a
matrix of calcareous sandstones (filling interstices in the sandstone) and
conglomerates colored dark gray to black. Small flat rocks from the mine
were examined separately or were pulverized into a fine dust placed in
heavy plastic bags as ‘mud packs’ of sizes that ranged from about 10 to 30
cm square. The packs helped to minimized dose in-homogeneity.
Beta/gamma dose-rates for the radiation sources were measured in
Pritchett, Colorado with an ‘Inspector Alert’ nuclear radiation monitor
manufactured by International Medcom (United States) and differential
γ-ray dose-rates were measured in Korea with a γ-detector which had a
photon energy range of 30 keV to 1.2 meV. The natural background γ
dose-rate at 91 cm above the ground was 0.28 µGy/h in Daejeon, Korea
and 0.55 µGy/h in Pritchett, Colorado. Gamma-ray spectroscopy was per-
formed on the surface area of a small flat rock (8 x 5 x 0.6 cm) that had
a surface γ-dose-rate of 11µGy/h. The spectrum was quite different from
that seen with typical uranium ore samples (Figure 1). Presumptive
radionuclides detected in the Utah rock included 214Bi, 214Pb, 125Xe, 226Ra,
133Ba, 196Au, 111mCd, 114In, 237Pu and 242Am. This made the rocks consid-
erably more radioactive than typical uranium-bearing mine samples.
Laser-induced breakdown fluorescence spectroscopy was used for ele-
mental analysis on a small flat rock (7 x 5 x 1 cm) that had a dose rate of
9.8 µGy/h. The entire rock had a high vanadium content. One circular
area had a high uranium content which was associated with a small
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amount of americium (spectral lines 356.916 nm, 367.312 nm, and
466.279 nm).
Beta/gamma dose-rates for the surface of rocks and mud packs
ranged from ~10 to 500 µGy/hr. The γ-ray surface dose-rates ranged from
~1 to 70µGy/h. The γ-ray dose rate in air was determined at intervals up
to 28 cm from the rock surface for six rocks which had surface dose-rates
of 9.8 to 43 µGy/hr. The mean half-value distance for γ-rays in air was
about 1.5 cm with 10% of surface dose-rate found at about 8.5 cm and
2.5% of the surface dose found at 20-28 cm from the rock surface. The
dose-rate distribution with increasing distance from the rock surface is
not what one would expect from a single γ-ray photon because it repre-
sents a composite of hundreds of different γ-ray energies.
The differential air dose contribution by radiation types for rocks and
mud packs were 93% β and 7% γ at their surface. No significant differ-
ences were noted in β/γ differential air dose contributions among the
rocks or packs. The maximum range of β-particles, with energies > 0.8
MeV, in soft tissue is about 1/2 their energy in MeV given as range in cm.
Thus, a 2.3 MeV β-particle has a range of about 1.1 cm and a 1.1 MeV β-
particle has a range of about 0.5 cm in soft tissue. The vast majority of β-
energy from the rock samples would be absorbed by the first cm of skin.
All experimental dose-rates from the rocks or mud packs were taken
at their surface or at intervals of distance in air from their surface. Dose-
rates were either combined β + γ radiation or γ radiation alone. Dose was
determined as a simple measure of dose-rate in µGy/h x time in hours.
Two cases closely observed by the author were successfully treated
(with their consent) by uranium ore mud packs:
C. L. Sanders
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FIGURE 1. Surface γ-ray spectroscopy of a small flat rock from a uranium mine in Utah; the surface
γ-dose-rate was 11µGy/h. 
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Case 1: A dozen 3-7 mm warts on a 5 x 8 cm skin patch near the knee,
had been repeatedly treated about every six months, with cryosurgery for
the last 10 years. The warts were treated with a 12 cm square mud pack
for a few hours a day for six continuous weeks; the dose-rate was 70
µGy/hr and the total dose was 15 mGy. The warts and cryosurgical scars
disappeared by 6 weeks and have not returned after 24 months. The skin
was healthy and normal following treatment. Treatment was not been
repeated.
Case 2: Two raised lesions of seborrheic keratoses on the left shoulder
about 5 cm apart were treated with a 1cm thick 7 x 15 cm flat radioactive
rock for a few hours a day for four consecutive weeks; the dose-rate was
250 µGy/h and the total dose was 19 mGy. The lesions disappeared and
have not returned after 44 months. The skin was healthy and normal fol-
lowing treatment. Treatment was not repeated.
A more recent case is presented of a 50 year-old woman who was diag-
nosed with adenocarcinoma of the left breast by needle biopsy on
September 2011. A PET scan showed no metastatic disease and no lymph
node involvement. She declined chemotherapy, radiation therapy or sur-
gery. In the spring of 2012, the patient developed a cough and breathing
difficulty that was evaluated by x-ray, showing multiple nodules in both
lungs consistent with metastatic disease. The primary tumor size at this
time was a firm mobile mass of 10 cm in diameter. She went to Pritchett,
Colorado in early April 2012 where she received near continuous expo-
sures to the front and back of the chest from mud packs delivering an
average of about 100 µGy/hr at the pack surface. Total dose to the chest
after 7 weeks of continuous therapy was ~150 mGy. The size of the pri-
mary tumor decreased about 40% in diameter at this time with improve-
ment in breathing and cough. Observations a few weeks later by a differ-
ent physician indicated that the primary tumor was ‘dead’ being com-
prised of necrotic tissue. The patient subsequently received high dose
radiotherapy to the head for brain metastases and is currently receiving
low dose iv chemotherapy along with near continuous treatment with
mud packs.
Case studies have also been provided by Jay Gutierrez (personal com-
munication, 2012) from individuals seen at his radon clinic in Pritchett,
Colorado. A medical doctor (MD) is also associated with the clinic.
Among medical conditions claimed by Gutierrez to have positive respons-
es to low-dose radiation therapy using radioactive rocks/packs are cancer,
ragweed allergy, Dupuytren’s contracture, Meniere’s disease, wet
retinopathy, rheumatoid arthritis and circulatory failure associated with
diabetes. Total doses used were estimated to be in the range 10-500 mGy,
chronically given over weeks to months. Sufficient medical records and
dose details are not available to adequately document these cases.
Low Dose Radiation Effects and Therapy
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DISCUSSION
Cellular Mechanisms of Radiation Hormesis
Early 20th century radioprotection limits were based on the maxi-
mum permissible dose that implied the existence of a threshold. The
LNT assumption was introduced later as a substitute and applies to sto-
chastic effects such as cancer and genetic changes. The LNT assumption
suggests that carcinogenic and other stochastic health effects, do not
exhibit a threshold, and are cumulative over a lifetime. A single-hit (to
cell nucleus) model of radiation-induced mutations (which can lead to
cancer) provided the rationale for the LNT assumption, based initially on
observations of mutations in fruit fly germ cells (Muller 1927). Muller’s
work involved very high X-ray doses so that no conclusive results could be
obtained related to low radiation doses and he ignored data that showed
a threshold at what was then considered low doses (Calabrese 2011), but
were quite high compared to today’s definition of low dose ( < 100 mGy).
Koana et al. (2004) found a threshold at about 1000 mGy for somatic
mutations in fruit flies. In a later study, the frequency of sex-linked reces-
sive lethal mutations in fruit fly germ cells was significantly lowered from
the un-irradiated control group by a γ-ray dose of only 500 µGy (Ogura
2009). This observation can be considered to be a protective bystander
effect, since at the indicated dose fewer than one electron track (from
ionizing events) per cell would be expected. The protection relates to an
adaptive response occurring as a result of the mild radiation stress
imposed.
DNA damage and other stresses can trigger a highly conserved, anti-
cancer, anti-aging survival response (adaptation) that suppresses metabo-
lism and growth and boosts defenses that maintain the integrity of the cell
(Hoeijmakers 2009). Protective cellular responses to ionizing radiation
include DNA repair, intracellular metabolic redox reactions, cell cycle
checkpoint controls, intra- and inter-cellular signaling cascades, apopto-
sis and mitotic linked cell death. These mechanisms are activated by low
radiation doses that result in non-linear responses, producing an adaptive
response that reduces the spontaneous or background level of cell trans-
formations, cancer, heart disease or other diseases (Dauer et al. 2010).
Thresholds and Hormesis in Radiation Carcinogenesis
Natural background radiation varies by geographic location up to
nearly three orders of magnitude (0.5 to 300mSv/y). No increase in mor-
tality from diseases has been observed for people living in high back-
ground dose regions (Mortazavi and Karam 2005). Data on deaths from
all causes and cancers among workers in the nuclear industry were eval-
uated by the International Agency for Research on Cancer (Vrijheid et al.
2007). The low SMRs for all-cancer mortality (0.74) and all-cause mortal-
C. L. Sanders
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ity (0.62) are examples of radiation hormesis rather than a HWE
(Healthy Worker Effect) (Kojiro 1999; Fornalski and Dobrzynski 2009,
2010). These data are consistent with the earlier findings (Luckey 2007;
2008b; Rockwell and Muckerheide, 2008) that workers chronically
exposed to low dose radiation exhibit significantly lower SMRs for all
mortality and cancer mortality than in unexposed control groups. A study
of 250,000 nuclear workers found an average mortality of 67 ± 13% com-
pared to the control group (Luckey 2007, 2008a). A decreased cancer
mortality was also observed in radiotherapy patients in organs outside
high dose therapy regions of the body (Luckey 2008b). An environmen-
tal survey of the US indicates that overall cancer mortality would be neg-
ligible at an annual whole-body, presumably low LET radiation dose of 7
mGy (Frigerio et al. 1973).
Cancer was significantly reduced (SMR ~0.80) in 240,000 Chernobyl
emergency workers who received a dose of 100 mSv (Jaworowski 2010).
Several 60Co orphan sources were inadvertently recycled into 20,000 tons
of structural steel which was used to construct about 200 residential,
industrial and school buildings in 1982 housing 10,000 residents of
Taiwan. The average cumulative dose for the exposed residential popula-
tion was about 50 mSv (Chang et al. 1997); the average dose-rate was esti-
mated at11 µSv/h. Only seven fatal cancers were observed out of an
expected 232 (SMR = 0.03) (Chen et al. 2004). A latter paper showed an
observed cancer incidence of 95 out of an expected 115 (SIR = 0.8) which
was significantly less than expected (Hwang et al. 2006); this paper used
10 year lagging (throwing away radiation dose) for solid cancers, result-
ing in a misrepresentation of the true dose and cancer risk and also did
not provide any SMR values. SIR values that are considerably higher than
SMR values for cancer may represent, in part, a therapeutic effect of low
dose radiation on cancer progression.
Young adult beagle dogs have been exposed to a variety of α, β, γ
radionuclides by ingestion and inhalation, thresholds from 0.5 to 20 Gy
were found for leukemia, bone tumor and lung tumor formation in lifes-
pan studies carried out during the last fifty years (Raabe 2010). The
threshold dose for bone cancer in radium dial painters was 10 Gy; a large
majority of painters received less dose and ended up living longer than
the unexposed control population (Sanders 2010). The threshold for
lung tumors in rats, dogs and Mayak workers exposed to alpha radiation
plutonium-239 aerosols ranged from 0.4 to 0.8 Gy (Sanders and
Lundgren 1995; Sanders 2008; Tokarskaya et al. 1997) when combined
with chronic gamma irradiation. Low LET gamma rays appear to activate
natural protection against high-LET alpha-radiation-induced lung cancer
from plutonium-239 and also radon-progeny. Greater than 80% of pluto-
nium-239 alpha-radiation-induced rat lung cancers were prevented by
chronic, low dose-rate gamma-ray exposure. Interestingly, lifetime expo-
Low Dose Radiation Effects and Therapy
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sure to residential radon at the Environmental Protection Agency’s action
level of 4 pCi L-1 appears to be associated with on average a > 60% reduc-
tion in lung cancer cases from associated low LET radiations (Cohen
1995, 1997). The threshold for lung cancer in humans exposed to low
LET radiation ranges from 1-2 Gy (Sanders and Scott 2008).
Optimal Beneficial Doses and Dose-Rates
Very small doses and dose-rates of radiation often exhibit significant
health hormetic effects based on observations in epidemiological and
experimental studies (Sanders 2010). Low doses and dose rates of ioniz-
ing radiation have been defined by UNSCEAR and BEIR VII as those
below 100-200 mGy and below 50-100 mGy/min, respectively. Uniform,
whole-body, continuous, low-LET radiation exposure was estimated to
cause no excess risk of radiation-induced cancer at dose-rates < 150
mSv/y in humans (Keirim-Markus 2002). For the system studied, the
adaptive response operates within these dose and dose-rate limits.
An inverse dose-rate effect has been observed with low LET radiations
for radioadaptive cellular and therapy mechanisms (Gridley et al. 2005;
Leonard 2007). A low dose/dose-rate microdosimetry model for radia-
tion hormesis has been proposed (Feinendegen 2003) based on observa-
tions in mammalian cells. Cellular lesions are eliminated by the disap-
pearance of genomically damaged cells at doses < 10 mGy while repair sys-
tems are activated at > 10 mGy. An adaptive response is seen in mam-
malian cells between a dose range of < 1 mGy and 100 mGy for a single
low-LET exposure (Mitchel 2010). The consequences of oxyradical-
caused cell damage is reduced once a cell has sensed the radiation by an
electron or photon traversal.
The adaptive response causes genomic instability related outcomes,
such as cell transformation and chromosomal aberration formation, to
decrease below the normal background or spontaneous levels following
exposure to ultra-low doses and dose-rates. Cellular hormesis responses
from natural and anthropogenic sources of radiation are similar
(Pollycove and Feinendegen 2003). However, dose-rates from anthro-
pogenic radiation sources are typically much higher than from natural
sources (Ulsh 2010).
Bio-positive effects were estimated to be between 1 mSv and 1000
mSv/y (Luckey, 2008a; Gregoire and Cleland, 2006). Radiation protocols
showing evidence of radiation hormesis for γ-dose-rates are found in the
1-50 µSv/hr dose-rate range. Optimal bio-positive effects were estimated
to be at a dose-rate of 100 mGy/yr or 11 µGy/hr given as a continuous
exposure (Cuttler and Pollycove 2009). Luckey (2008a) estimated the
optimal radiation level as 60 mGy/yr or 6.9 µGy /hr. Luckey (2008b) also
estimated that 50 mSv/y would reduce cancer mortality to near zero and
C. L. Sanders
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that the elimination of cancer deaths would increase lifespan by about 10
years.
Are there optimal photon energies that stimulate hormetic reactions?
A few studies have examined the role of photon energy. Experimental evi-
dence is limited. Lower energy x-rays were more efficient in inducing
genomic instability than γ-rays while higher energy γ-rays and 60 kvp x-
rays were more efficient in activating the Protective Apoptosis Mediated
(PAM) response than 28 kvp x-rays (Scott 2005). If you could chronically
deliver the right gamma ray energy spectrum to critical cellular sites at
the same time, then you might expect to see more significant positive bio-
medical effects, both in prevention and in therapy for inflammatory and
proliferative diseases, at ultra-low dose- rates.
Tumor Cell Response at Low Doses
Low dose radiation-induced enhancement of apoptosis and self-
destruction of transformed or pre-cancerous cells represents a potential
control system during carcinogenesis (Bauer, 2007). Tumor cell apopto-
sis is stimulated by < 10 mGy of low-LET radiation (Cotter 2009).Very low
priming doses increase latency for cancer induction in experimental ani-
mals (Wolff 1996; Tapio and Jacob 2007).Very low dose-rates cause cell
transformation at 2 mGy/day (Elmore et al. 2009), simulate apoptosis in
mice with knock-out gene at 1.2 mGy/hr (Ina and Sakai 2005), suppress
thymic lymphoma at 1.2 mGy/hr (Ina et al. 2005), increase lifespan at 25-
50 x background dose (Caratero et al. 1998), and suppress methylcholan-
threne-induced skin tumors at 1.2 mGy/hr (Sakai et al. 2003).
Low dose radiotherapy modulates the immune-inflammatory
response (Rodel et al. 2007). A dose of 200 mGy enhanced phagocytosis
by macrophages and increased CD8+ T cell production in mice (Pandey
et al. 2005). LDR (Low Dose Radiotherapy) up-regulated genes that
encode cytokines at doses as low as 100 mGy (Barcellos-Hoff 1998).
Continuous gamma ray exposure (100 mGy per year) prolonged lifespan,
suppressed B-cell lymphoma formation and increased CD49+ cell pro-
duction in mice (Lacoste-Collin et al. 2007). A single dose of 100-200 mGy
x-rays to mice reduced lung metastases from implanted syngeneic L1 sar-
coma cells, while also increasing NK cell numbers (Cheda et al. 2004).
Single daily doses of 330 µGy at 700 µGy/hr in mice to a total dose of
146 mGy delivered over a period of 90 weeks inhibited tumorigenesis
(Mitchel et al. 2008). A dose of 10 mGy increased cancer latency and
decreased cancer incidence in cancer prone mice (Mitchel et al. 2003).
Low doses of TBI (Total Body Irradiation) significantly delayed SaI tumor
cell growth in mice (Anderson et al. 1982). Lower doses delivered over an
extended period of time may preferentially sensitize tumor cells, while
inducing radio-resistance in normal cells due to the radio-adaptive
response. Continuous administration of ultra-low level radiation with
Low Dose Radiation Effects and Therapy
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either 125I seeds or whole body exposure to 137Cs γ-rays significantly
increased the efficacy of HDR (High Dose Radiotherapy) for implanted
human malignant glioma cells in athymic mice (Williams et al. 1998). Low
dose TBI reduced the incidence of spontaneous lymphoma in mice (Ishii
et al. 1996).
A threshold dose-rate effect was seen for skin tumor by localized β-
irradiation (Ootsuyama and Tanooka 1991). Exposure of mouse skin to
500 mGy β-irradiation at 24 hr before treatment with methyl-nitro-nitroso
guanidine, reduced papilloma formation by five-fold but had no signifi-
cant effect on carcinoma formation (Mitchel et al. 1999). Administration
of tritium to mice in drinking water protected against thymic lymphoma
formation up to a dose-rate of 900 mGy/day (Yamamoto et al. 1998). A
dose of 100 mGy of 6 MeV x-rays given 24 hours before start of radio-
therapy with 48 Gy in 16 x 3 Gy fractions to dogs with oral cancer caused
a cytoprotective effect to surrounding normal tissues (Blankenbecler
2010).
Geology and Radioactivity of Uranium-Bearing Sandstone
Uranium mine tailings are not considered to be significantly radioac-
tive. However, there are exceptions (McLeary 2004; Chareyron 2008;
Sengiyumva 2010). Uraniferous mineralization consists primarily of the
oxides, uraninite and pitchblende (Augustithis, 1995).The 238U/235U
ratio has generally been considered invariant in nature with a value of
137.8. However, two modal values of the isotopic ratio exist with a signifi-
cant relative difference of 0.03% in uranium ores with the lower mode
being found in some mines of the Colorado Plateau. This could be attrib-
uted to separation from 238U and depletion of 235U by in situ geological
nuclear reactions (Cowan and Adler 1976). Uranium deposits form when
groundwater with leached uranium is reduced to precipitate uraninite.
This is a possible mechanism by which 235U can be fractionated from 238U
in ground waters at low temperature in the redox state transition of ura-
nium (U6+ ↔ U4+) (Stirling et al. 2007) . Sufficient separation and con-
centration of 235U to ~3% level required to sustain a nuclear reaction
appeared to have occurred in the uranium-bearing rocks examined in
this study. Water also serves as a neutron moderator.
The contribution from actinides and their daughter products to beta
decay in CANDU (CANadianDeuteriumUranium) reactor spent fuel
becomes significant after 200 years and is dominant at times greater than
300 years, at which time the radiation dose is predominantly from beta
decay (Garisto et al. 2009). Very low level levels of transuranics were also
found in pitchblende and uraninite ores from Canada and Belgium
Congo (Levine and Seaborg 1951; Ridenour 1961). The rocks from Utah
also exhibit predominantly beta decay. The presence of ‘excess’ radioac-
tivity, transuranics and fission products and β, γ dose-distribution in the
C. L. Sanders
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Utah rocks indicates a probably origin from an in situ nuclear reaction
hundreds to thousands of years ago.
Low Dose Radiotherapy for Inflammatory and Proliferative Diseases
A pooled analysis of twenty-eight radon epidemiological studies indi-
cates that radon does not cause lung cancer up to a lung dose of 150 mSv
(Fornalski and Dobrzynski 2011). The lung cancer rate in the lowest
radon states was nearly four times greater than predicted by the LNT
while the lung cancer rate in the highest radon states was one-seventh of
the LNT prediction (Rockwell and Muckerheide 2008). The low-LET
component from radon progeny was probably responsible for the strong
hormetic effect described for lung cancer by Cohen (1995) in an ecolog-
ical radon study and by Thompson et al (2008) in a case-control residen-
tial radon study.
Radon therapy is widely available in Europe to treat a variety of chron-
ic inflammatory and painful diseases. These include rheumatoid arthritis,
lupus, scleroderma, ankylosing spondylitis, asthma, bronchitis and psori-
asis (Erickson 2007). Falkenbach et al (2005) described five trials of radon
therapy for rheumatoid arthritis, three of which were double-blind that
showed beneficial effects. Radon therapy was also effective in treating
osteoarthritis (Yamaoka et al. 2004), bronchial asthma (Mitsunobu et al.
2003), and dyslipidemia associated with cardiovascular disease (Iashina et
al. 2011). The standard uranium mine therapy for the Free Enterprise
Radon Health Mine in Boulder, Montana recommends a stay of 40 hours
in the mine spread over 10 consecutive days. The average mine radon
concentration is 1200 pCi/l. This gives a cumulative lung dose of ~6 mSv
(150 µSv/h). The dose schedule in the Free Enterprise mine has been
found effective for treating a variety of inflammatory diseases in several
thousand people during the last several decades. The bio-positive effects
of radon therapy typically last from 6 to 12 months (Lewis 2011). Similar
radiation doses are given in European radon therapy protocols. In com-
parison, the radioactive rocks from Utah gave β/γ−dose-rates that ranged
from 21 to 450 µGy/h and γ-dose-rates that ranged from ~1 to 30µGy/h
at the source surface.
India has about 30% of the world’s thorium reserves including mon-
azite-bearing beach sands. Monazite contains 2-7% thorium by weight
with nearly all thorium comprised of 232Th. Thoriated gas mantles are
widely used in India for lighting both outdoors and indoors resulting in
annual effective doses of 2 and 8 mSv, respectively (Ramachandran 2010).
People in parts of Iran use the ash from burned thorium-containing man-
tles for healing of skin wounds. Radioactive lantern mantle ash enhanced
the healing of excision wounds in the skin of rats (Mortazavi et al. 2009).
The Kerala and Orissa monazite-bearing beach sands of India give
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absorbed γ-dose-rates in air that range to over ten times background rate
in most other areas of India (Mahur et al. 2009; Rao et al. 2009).
A group of four patients with advanced cancer and two patients with
severe rheumatoid arthritis and dermatomyositis were exposed to radon
and γ-rays from monazite sand for one hour, three times weekly, for a peri-
od of 3 to 36 consecutive months. Radon (200 pCi/l) delivered a dose to
the lung of 25 µSv/h while monazite delivered 40 µSv/hr from γ-rays. The
weekly dose was ~200 µSv and the monthly dose was ~1 mSv. All patients
had failed orthodox therapy. In each case bio-positive changes were
noted, including a decrease in tumor marker antigens, improved tumor
control, and improved appetite, muscle strength and exercise ability
(Takatori et al. 2010). Advanced cancer patients are currently being treat-
ed using thin silicon plates (50 X 50 cm) containing concentrated mon-
azite which give about 2000μSv/h from beta and gamma radiations
(Takatori, personal communication).
Prior to and into World War II, Roentgen radiation was used to treat-
ed a variety of infections (Kelley 1942). Single and fractionated doses of
x-rays of less than 1 Gy were successfully used to cure diphtheria, tuber-
culosis and gas gangrene, and limit inflammation of arthritis, rheumatism
and bronchitis (Cuttler 2004, 2008; Calabrese and Dhawan, 2012) and
ulcerative dermatitis (Mitchel et al. 2007). Radiotherapy with fractions of
mostly 0.3-1.0 Gy and a total dose of 3-12 Gy exerted anti-inflammatory
and analgesic effects for painful degenerative disorders. Relatively low
dose radiotherapy for joint inflammation was an effective and less toxic
alternative to steroids and low dose chemotherapy drugs in treating
arthritis (von Pannewitz 1933; Seegenschmiedt et al. 2000; Micke and
Seegenschmiedt 2002; Niewald et al. 2008). Low doses of radiation were
effective in treating ulcerative colitis if given chronically over a longer
period of time (Mitchel et al. 2007). Low dose TBI may control or even
cure AIDS (Shen et al. 1989, 1997)
Low dose radiation alone or in combination with other agents [e.g.,
agents that shut down cancer cell survival signaling pathways] has poten-
tial use in cancer therapy. Patients with multiple myeloma, lymphoma
and nasal carcinoma underwent tumor regression after receiving LDI
radiotherapy to a total dose of 1.5 Gy (Cuttler and Polycove 2009).
Implanted 125I seeds giving 40-70 mGy/hr, significantly improved survival
in glioblastoma patients also given external beam radiotherapy (Scharfen
et al. 1992). Fractionated whole-body doses (TBI) of 100 mSv or half-body
doses (HBI) of 150 mSv delivered three times or two times a week, respec-
tively, for a total dose of 1.5 Sv, significantly improved survival of patients
with non-Hodgkin’s lymphoma (Choi et al. 1979; Sakamoto 2004). Low
dose TBI decreased lung metastases (Hosoi and Sakomato 1993).
Radiation doses delivered in this study are one to two orders of magni-
tude lower than those used to treat cancer patients with TBI or HBI, given
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at dose-rates that are lower by four orders of magnitude. Low LET radia-
tion inhibits the development of spontaneous and artificial metastases in
humans and laboratory animals. This suggests that γ-irradiation may be
used to treat and cure cancer and prevent cancer metastases
(Nowosielska et al. 2010).
Evidence obtained from the review of low dose radiobiological stud-
ies in this paper and limited anecdotal observations in individuals given
low dose exposure to enhanced radioactive uranium ore, radon and mon-
azite sands should provide motivation to pursue controlled experimental
studies in animals and humans to evaluate their possible therapeutic uti-
lization in treating a wide variety of conditions associated with inflamma-
tion and cell proliferation. Low-dose radiation was successful in treating
warts, a model of virus-induced benign tumor, and seborrheic keratosis, a
model of squamous metaplasia. A small dose of radiation may be admin-
istered in a continuous fashion or at regular intervals for a long time.
However, radiation protocols currently lack any standard dose quantiza-
tion, dose fractionation and duration of a treatment course.
Mathematical models, computer simulations and clinical trials are war-
ranted to exploit the potential of low dose radiation therapy to control
and cure chronic and complicated diseases. It appears that low-dose radi-
ation therapy may have far reaching effects in controlling and curing
many diseases throughout the world. The application of ‘natural’ low
dose sources of ionizing radiation may be a particularly low cost, common
sense method for treating inflammatory and proliferative diseases with-
out apparent side-effects.
REFERENCES
Anderson RE, Tokuda S, Williams WL and Warner NL. 1982. Radiation-induced augmentation of the
response of A/J mice to SaI tumor cells. Amer. J. Path. 108:24-37.
Augustithis SS. 1995. Atlas of the textural patterns of ore minerals and metallogenic processes. De
Gruyter, Berlin, pp. 233-236.
Barcellos-Hoff MH. 1998. How do tissues respond to damage at the cellular level? The role of
cytokines in irradiated tissues. Radiat Res 150 (Suppl.) S109-S120.
Bauer G. 2007. Low dose radiation and intercellular induction of apoptosis: potential implications
for the control of oncogenesis. Int J Radiat Biol 83:873-888.
BEIR. 2006. Health risks from exposure to low levels of ionizing radiation: BEIR VII, Phase 2.
Committee to assess health risks from exposure to low levels of ionizing radiation. National
Academy of Sciences, National Academies Press, Washington, DC.
Blankenbecler R. 2010. Low-dose pretreatment for radiation therapy. Dose-Response 8:534-542.
Calabrese E. 2011. Muller’s Nobel lecture on dose-response for ionizing radiation: Ideology
orscience? Arch Toxicol 85:1495-1498.
Calabrese E and Dhawan G. 2012. The role of x-rays in the treatment of gas gangrene: Ahistorical
assessment. Dose-Response 10(4):626-643.
Caratero A, Courtade M, Bonnet L, Planel H and Caratero C. 1998. Effect of a continuous gamma
irradiation at a very low dose on the life span of mice. Gerontology 44:272-276.
Chang WP, Chan CC and Wang JD. 1997. 60-Co contamination in recycled steel resulting in elevated
civilian radiation doses: causes and challenges. Health Phys 73:465-472.
Chareyron B. 2008. Radiological hazards from uranium mining. In: Uranium, Mining
andHydrogeology (BJ Broder and A Hasche-Berger, editors). Springer, pp. 451-458.
Low Dose Radiation Effects and Therapy
621
12
Dose-Response: An International Journal, Vol. 10 [2014], Iss. 4, Art. 15
https://scholarworks.umass.edu/dose_response/vol10/iss4/15
Charfen CO, Sneed PK, Wara WN, Larson D, Philips T, Prados M, Weaver K, Malec M, Acord P,
Lamborn K, Lamb S, Ham B and Gutin P. 1992. High activity iodine-125 interstitial implant for
gliomas. Int J Radiat Oncol Biol Phys 24:583-591.
Cheda A, Nowosielska EM, Wrembel-Wargocka J and Janiak MK. 2008. Production of cytokines by
peritoneal macrophages and splenocytes after exposures of mice to low doses of X-rays. Radiat.
Environ Biophys 47:275-283.
Cheda A, Wrembel-Wargocka J, Lisiak E, Nowosielska E, Marciniak M and Janiak M. 2004. Single low
doses of x-rays inhibit the development of experimental tumor metastases and trigger the activ-
ities of NK cells in mice. Radiat Res 161:335-341.
Chen WL, Luan YC, Shieh MC, Chen ST, Kung HT, Soong KL, Yeh YC, Chou TS, Mong SH, Wu JT,
Sun, CP, Deng WP, Wu MF and Shen ML. 2004. Is chronic radiation an effective prophylaxis
against cancer? J Amer Physicians Surgeons 9:6-10.
Choi NC, Timothy AR, Kaufman SD, Carey RW and Aisenberg AC. 1979. Low dose fractionated whole
body irradiation in the treatment of advanced non-Hodgkin’s lymphoma. Cancer 43:1636-1642.
Cohen BL. 1997. Lung cancer rate vs. mean radon level in U.S. counties of various characteristics.
Health Phys 72:114-119.
Cohen BL. 1995. Test of the linear-no-threshold theory of radiation carcingenesis for inhaled radon
decay products. Health Phys 68:157-174.
Cotter TG. 2009. Apoptosis and cancer: the genesis of a research field. Nature Reviews/Cancer 9:501-
507.
Cowan GA and Adler HH. 1976. The variability of the natural abundance of 235U. Geochimicaet
Cosmochimica Acta 40:1487-1490.
Cowan GA. 1976. A natural fission reactor. Sci Amer, pp. 235-236.
Cuttler JM and Pollycove M. 2009. Nuclear Energy and health. Dose-Response 7:52-89.
Cuttler JM. 2004. Low-dose irradiation therapy to cure gas gangrene infections. Int J Low Radiat
1:318-328.
Cuttler JM. 2008. Book review: Roentgen treatment of infections by JF Kelly and DA Dowell. Can Nucl
Soc Bull 29:43-44.
Dauer LT, Brooks AL, Hoel DG, Morgan WF, Stram D and Tran P. 2010. Review and evaluation of
updated research on the health effects associated with low-dose ionizing radiation. Radiat Prot
Dosim 140:103-136.
Elmore E, Lao X-Y, Kapadia R and Redpath JL. 2009. Threshold-type dose response for induction of
neoplastic transformation by 1 GeV/nucleon iron atoms. Radiat Res 171:674-770.
Erickson BE. 2007. The therapeutic use of radon: a biomedical treatment in Europe; an alternative
remedy in the United States. Dose-Response 5:48-62.
Falkenbach A, Kovacs J, Franke A, Jorgens K and Ammer K. 2005. Radon therapy for the treatment
of rheumatic diseases—review and meta-analysis of controlled clinical trials. RheumatolInt 25:
205-210.
Feinendegen LE. 2003. Relative implications of protective responses versus damage induction at low
dose and low-dose-rate exposure using microdose approach. Radiat Prot Dosim 104:337-346.
Fornalski KW and Dobrzynski L. 2009. Ionising radiation and the health of nuclear industry workers.
Int J Low Radiat 6:57-78.
Fornalski KW and Dobrzynski L. 2010. The healthy worker effect and nuclear industry workers. Dose-
Response 8:125-147.
Fornalski KW and Dobrzynski L. 2011. Pooled Bayesion analysis of twenty-eight studies on radon
induced lung cancer. Health Phys 101:265-273.
Frigerio NA, Eckerman RF and Stowe RS. 1973. Carcinogenic hazard from low-level, low-rate radia-
tion. Part 1, Report ANL/ES-26, Argonne, IL, Argonne National Laboratory.
Garisto F, Barber DH, Chen E, Inglot A and Morrison CA. 2009. Alpha, beta and gamma dose rates
in water in contact with used CANDU fuel. NWMO TR-2009-27, 41 pp. Nuclear Waste
Management Organization, Toronto, Canada.
Gregoire O and Cleland MR. 2006. Novel approach to analyzing the carcinogenic effect of ionizing
radiation. Int J Radiat Biol 82:13-19.
Gridley DS, Williams JR and Slater JM. 2005. Low-dose/low-dose-rate radiation: a feasible strategy to
improve cancer radiotherapy? Review article. Cancer Therapy 3:105-130.
Gutierrez J. 2012. Personal Communication.[ www.nighthawkminerals.com], Pritchett, Colorado
81064.
Hoeijmakers JH. DNA damage, aging and cancer. 2009. New Engl J Med 361:1475-1485.
C. L. Sanders
622
13
Sanders: Low Dose Radiation Effects and Therapy
Published by ScholarWorks@UMass Amherst, 2014
Hosoi Y and Sakomato K. 1993. Suppressive effect of low dose total body irradiation on lung metas-
tasis: dose dependency and effective period. Radiother Oncol 26:177-179.
Hwang SL, Guo HR, HsiehWA, Hwang JS, Lee SD, Tang JL, Chen CC, Chang TC, Wang JD and
Chang TC 2006. Cancer risks in a population with prolonged low dose-rate g-radiation exposure
in radiocontaminated buildings, 1983-2002. Int J Radiat Biol 82:849-858.
Ina Y and Sakai K. 2005. Further study of prolongation of life span associated with immunological
modification by chronic low-dose-rate irradiation in MRL-lpr/lpr mice: effects of whole-life irra-
diation. Radiat Res 163:418-423.
Ina Y, Tanooka H, Yamada Tand Sakai K. 2005. Suppression of thymic lymphoma induction by life-
long, low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice. Radiat Res
163:153-158.
Ishii K, Hosoi Y, Yamada S, Ono T and Sakamoto K. 1996. Decreased incidence of thymic lymphoma
in AKR mice as a result of chronic, fractionated low-dose total-body X-irradiation. Radiat Res
146:582-585.
Jaworowski Z. 2010. Observations on the Chernobyl disaster and LNT. Dose-Response 8:148-171.
Keirim-Markus, IB. 2002.Radiation exposure normalization taking account of specific effects at low
doses and dose-rates. Atomic Energy 93:836-844.
Kelley, JF. 1942. Roentgen Treatment of Infection. The Year Book Publishers, Chicago.
Koana T, Takasima Y, Okada O, Ikehata M, Miyakoshi J and Sakai K. 2004. A threshold exists in the
dose-response relationship for somatic mutation frequency induced by X-irradiation of
Drosophila. Radiat Res 161:391-396.
Kojiro K. 1999. The healthy worker effect in a long-term follow-up population. Japanese J Cancer
Clinics 45:1307-1310.
Lacoste-Collin L, Jozan S, Cances-Lauwers V, Pipy B, Gasset G, Caratero C and Courtade-Saidi M.
2007. Effect of continuous irradiation with a very low dose of gamma rays on lifespan and the
immune system in SJL mice prone to B-cell lymphoma. Radiat Res 168:725-732.
Leonard BE. 2007. Thresholds and transitions for activation of cellular radioprotective mechanisms-
correlations between HRS/IRR and the ‘inverse’ dose-rate effect. Int J Radiat Biol 83:479-489.
Levine CA and Seaborg GT. 1951. The occurrence of plutonium in nature. J Amer Chem Soc
73:3278-3283.
Lewis P. 2011. Personal communication. Free Enterprise Radon Health Mine, Boulder, MT
Luckey TD. 2007. Documented optimum and threshold for ionizing radiation. Int. J. Nuclear Law
1:378-409.
Luckey TD. 2008a. Radiation hormesis overview. RSO Magazine 8:22-39.
Luckey TD. 2008b. The health effects of low-dose ionizing radiation. J Amer Physicians Surgeons
13:39-42.
Mahur AK, Kumar R, Sengupta D and Prasad R. 2009. Radon exhalation rate in Chatrapur beach
sand samples of high background radiation area and estimation of its radiological implications.
Indian J Phys 83:1011-1018.
McLeary M. 2004. Radium Hill mine and low-level radioactive waste repository. Report Book 2004/9,
Government of South Australia.
Meshik AP. 2004. Record of cycling operation of the natural nuclear reactor in the Oklo area of
Gabon. Phys Rev Lett 93:182-302.
Micke O and Seegenschmiedt MH. 2002. Consensus guidelines for radiation therapy of benign dis-
eases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 52:496-513.
Mitchel RE, Jackson J, Morrison DP and Carlisle SM. 2003. Low doses of radiation increased the
latency of spontaneous lymphomas and spinal osteo-sarcomas in cancer-prone, radiation-sensi-
tive Trp 53 heterozygous mice. Radiat Res 159:320-327.
Mitchel RE, Gragtmans NJ, Morrison DP. 1999. Beta-radiation-induced resistance to MNNG initiation
of papilloma but not carcinoma formation in mouse skin. Radiat Res 121:180-186.
Mitchel RE, Burchart P and Wyatt H. 2007. Fractionated, low-dose-rate ionizing radiation exposure
and chronic ulcerative dermatitis in normal and Trp53 heterozygous C57BL/6 mice. Radiat Res
168:716-724.
Mitchel RE, Burchart P and Wyatt H. 2008. A lower dose threshold for the in vivo protective adaptive
response to radiation tumorigenesis in chronically exposed normal and Trp53 heterozygous
C57BL/g mice. Radiat Res 170:765-775.
Mitchel RE. 2010. The dose window for radiation-induced protective and adaptive responses. Dose-
Response 8:192-208.
Low Dose Radiation Effects and Therapy
623
14
Dose-Response: An International Journal, Vol. 10 [2014], Iss. 4, Art. 15
https://scholarworks.umass.edu/dose_response/vol10/iss4/15
Mitsunobu F, Yamaoka K, Hanamoto K, kojima S, Hosaki Y, Ashidak K, Sugita K and Tanizaki Y.
2003.Elevation of antioxidant enzymes in the clinical effects of radon and thermal therapy for
bronchial asthma. J Radiat Res 44:95-99.
Mortazavi SMJ and Karam PA. 2005. Apparent lack of cancer susceptibility among residents of the
high background area of Ramsar, Iran: can we relax our standards? In: McLaughin JP (editor),
The Natural Radiation Environment VII, Elsevier, Amsterdam, pp. 1141-1147.
Mortazavi SMJ, Rahmani MR, Rahnama A, Saeed-Pour A, Nouri E, Hosseini N and Aghaiee M. 2009.
The stimulatory effects of topical application of radioactive lantern mantle powder on wound
healing. Dose Response 7:149-159.
Muller HJ. 1927. Artificial transmutation of the gene. Science 116:84-87.
Niewald M, Seegenschmiedt MH, Micke O, Garber S and the GCGBD of the DEGRO (German
Society for Radiation Oncology). 2008. Randomized multicenter trial on the effect of radio-
therapy for plantar fasciitis (painful heal spur) using very low doses-a study protocol. Radiat
Oncol 3:327-332.
Nowosielska EM, Cheda A, Wrembel-Wargocka J and Janiak MK. 2010. Immunological mechanism of
the low-dose radiation-induced suppression of cancer metastases in a mouse model. Dose-
Response 8:209-226.
Ogura K, Magae J, Kawakami Y and Koana T. 2009. Reduction in mutation frequency by very low dose
gamma irradiation of Drosophila melanogaster germ lines. Radiat Res 171:1-8.
Ootsuyama A and Tanooka H. 1991. Threshold-like dose of local β irradiation repeated throughout
lifespan of mice for induction of skin and bone tumors. Radiat Res 125:98-101.
Pandey R, Shankar BS, Sharma D and Salnis B. 2005. Low dose radiation induced immunomodula-
tion: effect on macrophages and CD8+ T cells. Int J Radiat Biol 81:801-812.
Pollycove M and Feinendegen LE. 2003. Radiation-induced versus endogenous DNA damage: possi-
ble effect of inducible protective responses in mitigating endogenous damage. Hum Exp
Toxicol 22:290-306.
Raabe OG. 2010. Concerning the health effects of internally deposited radionuclides. Health Phys
98:515-536.
Ramachandran TV. 2010. Environmental thoron (220Rn) : A review. Iran J Radiat Res 8:129-147.
Rao NS, Sengupta D, Guin R and Saha SK. 2009. Natural radioactivity measurements in beach sand
along southern coast of Orissa, eastern India. Environ Earth Sci 59:593-601.
Ridenour LN. 1961. Modern physics for the engineer. Volume 1, McGraw-Hill, p. 201.
Rockwell T and Muckerheide J. 2008. Testimony to the NRC’s Advisory Committee on Nuclear Waste
and Materials, Radiation, Science and Health, April 8.
Rodel F, Keilholz L, Herrmann M, Sauer R and Hildebrandt G. 2007. Radiobiological mechanisms in
inflammatory diseases of low dose radiation therapy. Int J Radiat Biol 83:357-366.
Sakai K, Hoshi Y, Nomura T, Oda T, Iwasak T, Fujita K, Yamada T and Tanooka H. 2003.Suppression
of carcinogenic processes in mice by chronic low dose-rate gamma-irradiation. Int J Low Radiat
1:142-146.
Sakamoto K. 2004. Radiobiological basis for cancer therapy by total or half-body irradiation.
Nonlinearity in Biology, Toxicology and Medicine 2:293-316.
Sanders CL and Lundgren D. 1995. Pulmonary carcinogenesis in the F344 and Wistar rat following
inhalation of 239PuO2. Radiat. Res. 144:206-214.
Sanders CL. 2008. Prevention of cigarette smoke induced lung cancer by low LET ionizing radiation.
Nuclear Engineering and Technology (Korea) 40:539-550.
Sanders CL. 2010.Radiation Hormesis and the Linear-No-Threshold Assumption. Springer-Verlag,
Germany, 214 pp.
Sanders CL and Scott BR. 2008. Smoking and Hormesis as Confounding Factors in Radiation
Pulmonary Carcinogenesis. Dose-Response 6:53-79.
Scott BR and Di Palma J. 2006. Sparsely ionizing diagnostic and natural background radiations are
likely preventing cancer and other genomic-instability-associated diseases. Dose-Response 5:230-
255.
Scott BR. 2005. Stochastic thresholds: A novel explanation of nonlinear dose-response relationships
for stochastic radiobiological effects. Dose-Response 3:547-567.
Seegenschmiedt MH, Katalinic A, Makoski H, Haase W, Gademann G and Hassenstein E. 2000.
Radiation therapy for benign diseases. Patterns of care study in Germany. Int J Radiat Oncol
Biol Phys 47:195-202.
C. L. Sanders
624
15
Sanders: Low Dose Radiation Effects and Therapy
Published by ScholarWorks@UMass Amherst, 2014
Sengiyumva G. 2010. Tanzania: Uranium reserves need proper handling. Tanzania Daily News,
February 1.
Shadley JD and Wolff JK. 1987. Very low doses of x-rays can cause human lymphocytes to become less
susceptible to ionizing radiation. Mutagenesis 2:95-96.
Shen RN, Lu L, Kaiser HE and Broxmeyer HE. 1997. Murine AIDS cured by low dosage total body
irradiation. Adv Exp Med Biol 407:451-458.
Shen RN, Hornback NB, Lu L, Li,L, Chen T, Brahmi A and Broxmeyer HE. 1989. Low dose total irra-
diation: a potent anti-retroviral agent in vivo. Int J Radiat Oncol Biol Phys 16:165-170.
Stirling CH, Andersen MB, Potter EK and Halliday AN. 2007. Low-temperature isotopic fractionation
of uranium. Earth and Planetary Science Letters 264:208-225.
Takatori M, Hattori S and Yagi M. 2010. Clinical significance of low-dose radiation therapy: radiation
hormesis. Int J Low Radiat 7:511-519.
Takatori M. 2011. Personal Communication
Tapio S and Jacob V. 2007. Radioadaptive response revisited. Radiat Environ Biophys 46:1-12.
Taylor LS. 1980. Some non-scientific influences on radiation protection standards and practice.
Health Phys 32:851-874.
Thompson RE, Nelson DF, Popkin JH and Popkin Z. 2008. Case-control study of lung cancer risk
from residential radon exposure in Worcester County, Massachusetts. Health Phys 94:228-241.
Tokarskaya ZB, Okladnikova ND, Belyaeva ZD and Drozhko EG. 1997.Multifactorial analysis of lung
cancer dose-response relationships for workers at the Mayak nuclear enterprise. Health Phys
73:899-905.
Ulsh BA. 2010. Checking the foundation: recent radiobiology and the linear no-threshold theory.
Health Phys 99:747-758.
Von Pannewitz G. 1933. Die Rontgentherapie der Arthritis de formans. Ergebnisse der medizmischen
Strahlenforschung 6:62-126.
Vrijheid M, Cardis E, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR,
Schubauer-Berigan M, Yoshimura T, Ahn Y-O, Ashmore P, Auvinen A, Bae J-M, Engels H, Gulis
G, Habib RR, Hosoda Y, Kurtinaitis J, Malker H, Moser M, Rodriguez-Artalejo F, Rogel A, Tardy
H, Telle-Lamberton M, Turai I, Usel M and Veress K. 2007. The 15-country collaborative study
of cancer risk among radiation workers in the nuclear industry: design, epidemiological meth-
ods and descriptive results. Radiat Res 167:361-379.
Williams JA, Williams JR, Yuan X and Dillehay LE. 1998. Protracted exposure radiosensitization of
human malignant glioma. Radiat Oncol Invest 6:255-263.
Wolff S. 1996. Aspects of the adaptive response to very low doses of radiation and other agents. Mutat
Res 358:135-142
Yamamoto O, Seyama T, Itoh H and Fujimoto. 1998. Oral administration of tritiated water (HTO) in
the mouse. III. Low dose-rate irradiation and threshold dose-rate for radiation risk. Int J Radiat
Biol 73:535-541.
Yamaoka K, Mitsunobu F, Hanamoto K, Mori S, Tanizaki Y and Sugita K. 2004. Study on biologic
effects of radon and thermal therapy on osteoarthritis. J Pain 5: 20-25.
Low Dose Radiation Effects and Therapy
625
16
Dose-Response: An International Journal, Vol. 10 [2014], Iss. 4, Art. 15
https://scholarworks.umass.edu/dose_response/vol10/iss4/15
